Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
0.00%
)
US TECH 100
23,685.20
(
1.73%
)
Dow Jones
45,577.47
(
0.00%
)
Brent Oil
99.72
(
-7.78%
)
Bitcoin
70,826.26
(
4.40%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Lewis R Goudy post# 2091

Monday, 12/04/2006 11:48:51 AM

Monday, December 04, 2006 11:48:51 AM

Post# of 19309
>Looking over the Atryn references I saw no mention of the University of Texas work on acute inhalation injury.<

If you have an abstract on this, I’ll add it to the reference list. I wonder if this will turn out to be a dead end like the antithrombin cancer program that GTCB licensed to Genzyme Molecular Oncology (GZMO) several years ago.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today